The Endpoints 11 celebrates biopharma's most promising startups. Live event on September 30
Next month John Carroll and the Endpoints editorial team continue a proud tradition of profiling a standout group of 11 startups that just might be headed for greatness. And we’re adding a new, live element that we want to share with all of you — and we’re asking for just one hour of your time.
Please mark your calendars for a 1-hour main event on September 30 at 4pm ET. The agenda will expand in the coming weeks, and we’ll have more than one hour’s worth of content for you. But the centerpiece of the 2020 Endpoints 11 is a one-hour live-streamed event.
It will start at 4pm ET / 1pm PT, and you can sign up with this link.
Our goal is to celebrate bold science in the pursuit of new biotech drugs, and that’s a lot easier said than done. When it comes to picking private companies, we’re dealing with incomplete and imperfect information. And the limits of our current understanding of biology can frustrate the most experienced scientific teams armed with tremendous financial backing. Regardless, we’re going to make our picks and argue our case for them. The companies that are in our sight are all swinging for the fences. Some will fail, but they each represent a trend in new biotech company creation. And they emerge from a historical backdrop, with the pandemic focusing the world’s attention on biopharma like never before.
This year we’re sponsored by Catalent, a company that has supported our independent mission at Endpoints from the start. This year, part of our agenda features my co-founder and Endpoints editor John Carroll presenting the awards live to the winners alongside Catalent CEO John Chiminski. Both “John C”s have a fun history of this kind of work, which we last saw at JP Morgan this year in San Francisco. It’s going to be a lot of fun and I hope you all can be a part of it.
Feeling Zoomed out? That’s understandable, and we’ll be working to keep your attention. There is a genuine need to continue the kind of celebratory events that would bring us together in a normal year — and we think this is worth your time. There’s more than one hour’s worth of content to share with you all, but the experience will be shaped in a way where the live show is the centerpiece. Everything else is on-demand. And there’s no cost to attend. You can sign up here.